01/17/2018
https://congress.gov...
"It makes it very difficult to ask her tough questions when she is so polite and receptive to my input."
"NNSA was a management experiment gone wrong."
"It looks to me like we have two issues here. We have an FDA issue, you are right, seeing Ms. Woodcock."
"I cannot overstate the importance of treating each biosimilar individually rather than as if they were a generic drug."